The Heart Failure Revascularisation Trial (HEART)

JGF Cleland; Melanie Calvert; Nick Freemantle; Y Arrow; SG Ball; Robert Bonser; S Chattopadhyay; MS Norell; DJ Pennell; R Senior

doi:10.1093/eurjhf/hfq230

The Heart Failure Revascularisation Trial (HEART)

JGF Cleland, Melanie Calvert, Nick Freemantle, Y Arrow, SG Ball, Robert Bonser, S Chattopadhyay, MS Norell, DJ Pennell, R Senior

Birmingham Medical School

Research output: Contribution to journal › Article

109 Citations (Scopus)

Abstract

Aims Revascularization is frequently advocated to improve ventricular function and prognosis for patients with heart failure due to coronary artery disease, especially when there is evidence of extensive myocardial viability. Methods and results Patients with heart failure, coronary artery disease, and a left ventricular (LV) ejection fraction

Original language	English
Pages (from-to)	227-233
Number of pages	7
Journal	European Journal of Heart Failure
Volume	13
Issue number	2
DOIs	https://doi.org/10.1093/eurjhf/hfq230
Publication status	Published - 1 Feb 2011

Keywords

Mortality
Heart failure
Myocardial viability
Randomized controlled trial

Access to Document

10.1093/eurjhf/hfq230

Cite this

@article{85f2aa0226284a41ba4b6b76dfa8381f,

title = "The Heart Failure Revascularisation Trial (HEART)",

abstract = "Aims Revascularization is frequently advocated to improve ventricular function and prognosis for patients with heart failure due to coronary artery disease, especially when there is evidence of extensive myocardial viability. Methods and results Patients with heart failure, coronary artery disease, and a left ventricular (LV) ejection fraction ",

keywords = "Mortality, Heart failure, Myocardial viability, Randomized controlled trial",

author = "JGF Cleland and Melanie Calvert and Nick Freemantle and Y Arrow and SG Ball and Robert Bonser and S Chattopadhyay and MS Norell and DJ Pennell and R Senior",

year = "2011",

month = feb,

day = "1",

doi = "10.1093/eurjhf/hfq230",

language = "English",

volume = "13",

pages = "227--233",

journal = "European Journal of Heart Failure",

issn = "1879-0844",

publisher = "Oxford University Press",

number = "2",

}

TY - JOUR

T1 - The Heart Failure Revascularisation Trial (HEART)

AU - Cleland, JGF

AU - Calvert, Melanie

AU - Freemantle, Nick

AU - Arrow, Y

AU - Ball, SG

AU - Bonser, Robert

AU - Chattopadhyay, S

AU - Norell, MS

AU - Pennell, DJ

AU - Senior, R

PY - 2011/2/1

Y1 - 2011/2/1

N2 - Aims Revascularization is frequently advocated to improve ventricular function and prognosis for patients with heart failure due to coronary artery disease, especially when there is evidence of extensive myocardial viability. Methods and results Patients with heart failure, coronary artery disease, and a left ventricular (LV) ejection fraction

AB - Aims Revascularization is frequently advocated to improve ventricular function and prognosis for patients with heart failure due to coronary artery disease, especially when there is evidence of extensive myocardial viability. Methods and results Patients with heart failure, coronary artery disease, and a left ventricular (LV) ejection fraction

KW - Mortality

KW - Heart failure

KW - Myocardial viability

KW - Randomized controlled trial

U2 - 10.1093/eurjhf/hfq230

DO - 10.1093/eurjhf/hfq230

M3 - Article

C2 - 21156659

SN - 1879-0844

VL - 13

SP - 227

EP - 233

JO - European Journal of Heart Failure

JF - European Journal of Heart Failure

IS - 2

ER -

The Heart Failure Revascularisation Trial (HEART)

Abstract

Keywords

Access to Document

Fingerprint

Cite this